Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 5
1971 2
1973 1
1976 2
1978 3
1980 4
1981 2
1983 1
1984 1
1987 1
1993 3
1995 1
1996 1
1998 2
1999 1
2000 5
2001 9
2002 8
2003 4
2004 8
2005 11
2006 8
2007 11
2008 11
2009 10
2010 3
2011 7
2012 13
2013 9
2014 16
2015 8
2016 8
2017 11
2018 15
2019 11
2020 12
2021 7
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Omata M, et al. Among authors: obi s. Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15. Hepatol Int. 2017. PMID: 28620797 Free PMC article. Review.
Nomograms should be noted.
Obi S, Omata M. Obi S, et al. Hepatol Int. 2024 Apr;18(2):420-421. doi: 10.1007/s12072-023-10612-y. Epub 2024 Mar 1. Hepatol Int. 2024. PMID: 38424395 No abstract available.
Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-α combination therapy for hepatocellular carcinoma with extrahepatic metastases.
Nagano H, Obi S, Hatano E, Kaneko S, Kanai F, Omata M, Tsuji A, Itamoto T, Yamamoto K, Tanaka M, Kubo S, Hirata K, Nakamura H, Tomimaru Y, Yamanaka T, Kojima S, Monden M. Nagano H, et al. Among authors: obi s. Hepatol Res. 2018 Aug;48(9):717-726. doi: 10.1111/hepr.13067. Epub 2018 Mar 12. Hepatol Res. 2018. PMID: 29377364
Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals.
Minami T, Sato M, Toyoda H, Yasuda S, Yamada T, Nakatsuka T, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Tanaka Y, Otsuka M, Ohki T, Arai M, Asaoka Y, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Nakagomi R, Akamatsu M, Mitsui H, Fujie H, Ogura K, Uchino K, Yoshida H, Hanajiri K, Wada T, Kurai K, Maekawa H, Kondo Y, Obi S, Teratani T, Masaki N, Nagashima K, Ishikawa T, Kato N, Yotsuyanagi H, Moriya K, Kumada T, Fujishiro M, Koike K, Tateishi R. Minami T, et al. Among authors: obi s. J Hepatol. 2023 Jun 24:S0168-8278(23)00424-5. doi: 10.1016/j.jhep.2023.05.042. Online ahead of print. J Hepatol. 2023. PMID: 37716372
Do female surgeons learn or teach differently?
Nebeker CA, Basson MD, Haan PS, Davis AT, Ali M, Gupta RN, Osmer RL, Hardaway JC, Peshkepija AN, McLeod MK, Anderson CI; MSU GOAL Consortium. Nebeker CA, et al. Am J Surg. 2017 Feb;213(2):282-287. doi: 10.1016/j.amjsurg.2016.10.010. Epub 2016 Dec 11. Am J Surg. 2017. PMID: 28139201
226 results